"A new consumer-friendly form ( is now available for making reports to MedWatch, the Food and Drug Administration's (FDA) on-line system for collecting information about serious problems with drugs, medical devices and other FDA-"...
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
DACLIZUMAB - INJECTION
COMMON BRAND NAME(S): Zenapax
USES: Daclizumab is used to prevent rejection of a kidney transplant. It works by weakening your body's defense system (immune system) to help your body accept the new kidney as if it were your own. This medication is a monoclonal antibody and belongs to a class of drugs known as immunosuppressants. It is used in combination with other immunosuppressant drugs (e.g., cyclosporine, corticosteroids such as prednisone).
HOW TO USE: This medication is given by injection into a vein by a health care professional. This medication is given over 15 minutes, usually every 14 days for a total of 5 doses, with the first dose given within 24 hours before transplantation, or as directed by your doctor. If you have any questions about the use of this medication, consult your doctor or pharmacist.
Dosage is based on your medical condition, weight, and response to treatment.
Additional Zenapax Information
Zenapax - User Reviews
Zenapax User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.